EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis

Guojun Yan, Kai Zhang, Lijun Yan, Yanbin Zhang

World Journal of Surgical Oncology · 2024

DOI: 10.1186/s12957-024-03464-9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift World Journal of Surgical Oncology, 2024. Verfasst von Guojun Yan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Yangfangdian Street, Haidian Dist…. Hauptthemen laut MEDLINE: Peritoneal Neoplasms, Cytoreduction Surgical Procedures, Pancreatic Neoplasms, Hyperthermic Intraperitoneal Chemotherapy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

Pancreatic cancer with peritoneal metastasis presents a challenging prognosis, with limited effective treatment options available. This study aims to evaluate the efficacy and safety of combining cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) as a treatment strategy for this patient group.

Methods

A retrospective analysis was conducted on patients with peritoneal metastasis of pancreatic cancer who underwent CRS + HIPEC treatment at Beijing Shijitan Hospital from March 2017 to December 2023. The study focused on assessing clinical features, the incidence of sever adverse events (SAEs), and overall survival (OS).

Results

A total of 10 patients were enrolled in this study. The median OS was 24.2 months, suggesting an improvement over traditional therapies. While SAEs were noted, including two cases of severe complications necessitating additional surgical interventions, no perioperative fatalities were recorded. The overall survival time for patients with CC0/1 was not significantly different from that of patients with CC2/3, and no prognostic predictors were identified.

Conclusions

The combination of CRS and HIPEC appears to be a viable and promising treatment modality for patients with peritoneal metastasis of pancreatic cancer, offering an improved survival rate with manageable safety concerns. Further research is needed to refine patient selection criteria and to explore the long-term benefits of this approach.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Peritoneal NeoplasmsCytoreduction Surgical ProceduresPancreatic NeoplasmsHyperthermic Intraperitoneal ChemotherapyHumansMaleFemaleRetrospective StudiesMiddle AgedSurvival RateCombined Modality TherapyPrognosisAgedFollow-Up StudiesAntineoplastic Combined Chemotherapy ProtocolsAdult

Stichwörter der Autor:innen

Cytoreductive surgeryHyperthermic intraperitoneal chemotherapyPancreatic cancerPeritoneal metastasis

Autor:innen und Institutionen

  • Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Yangfangdian Street, Haidian District, Beijing, 100038, China.
  • Department of Peritoneal Cancer Surgery, Beijing Shijitan Hospital, Capital Medical University, No. 10, Tieyi Road, Yangfangdian Street, Haidian District, Beijing, 100038, China. sjtyyzyb@mail.ccmu.edu.cn.

Zitieren

APA

Yan, G., Zhang, K., Yan, L., & Zhang, Y. (2024). Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis. World Journal of Surgical Oncology. https://doi.org/10.1186/s12957-024-03464-9

Vancouver

Yan G, Zhang K, Yan L, Zhang Y. Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis. World Journal of Surgical Oncology. 2024. doi:10.1186/s12957-024-03464-9

BibTeX
@article{Yan2024,
  author = {Yan, Guojun and Zhang, Kai and Yan, Lijun and Zhang, Yanbin},
  title = {Efficacy and safety of cytoreductive surgery combined with hyperthermic intraperitoneal chemotherapy in patients with pancreatic cancer peritoneal metastasis},
  journal = {World Journal of Surgical Oncology},
  year = {2024},
  doi = {10.1186/s12957-024-03464-9}
}
Kostenlos starten →